Researchers at EPFL, UNIL and CHUV have developed a
Researchers at EPFL, UNIL and CHUV have developed a
Researchers from EPFL have developed a novel series
and personalized medicine Researchers from EPFL have
Researchers at EPFL have developed a method to stimulate
embryonic tissues on a chip Researchers at EPFL have
EPFL scientists have carried out a genomic and evolutionary
proteins that domesticated our genomes EPFL scientists have
Researchers at Eawag, the ETH and the EPFL have now
Researchers at Eawag, the ETH and the EPFL have now
advised fund of Silicon Valley Community Foundation, have
advised fund of Silicon Valley Community Foundation, have
For years, attempts have been made to understand the
new therapies against cancer For years, attempts have
Scientists are exploring the proteins’ potential as a way to control CRISPR and reduce off-target effects.
But CRISPR faces safety concerns because scientists have
Three studies showing large DNA deletions and reshuffling heighten safety concerns about heritable genome editing.
gene-editing tool CRISPR–Cas9 to modify human embryos have
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), a gene-editing tool, is a promising way to treat diseases by removing, adding, or altering sections of deoxyribonucleic acid (DNA) sequences. It is currently the most straightforward, most flexible, and accurate method of gene manipulation.
Previous studies have shown the tool as a potential
